Retraction Note: LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement Authors: Cong Zhang, Huixia Wang, Qingwei Liu, Suli Dai, Guo Tian, Xintong Wei, Xiaoya Li, Lianmei Zhao, Baoen Shan Published: 2026 Retraction Note: J Exp & Clin Cancer Res 42, 246 (2023) https://doi.org/10.1186/s13046-023-02827-6 The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding data and image irregularities and animal ethics approval. Specifically, Fig. 3F, PKM1 (siNC) and Fig. 3F, PKM1 (CCAT1) appear to be highly similar. Upon request, the authors provided the original data, however, the blot provided for Fig. 3F, PKM1 (siNC) appears to show a discrepant result to the one in the article. Concerning the animal in vivo studies, it appears that the research was not conducted in compliance with international best practice standards as the ethics approval document did not match with the experiments carried out in this study. In addition, MGC-803, SGC-7901 and BGC-823 cell lines have been reported to be contaminated with HeLa and are therefore unsuitable for gastric cancer research [1–4]. Therefore, the Editor-in-Chief no longer has confidence in the presented data. Lianmei Zhao agrees with this retraction. Cong Zhang, Huixia Wang, Suli Dai, Xintong Wei and Xiaoya Li did not explicitly state whether or not they agree with this retraction. Qingwei Liu, Guo Tian and Baoen Shan did not respond to correspondence from the Publisher about this retraction.